DC Circ. Won't Rethink HHS Cuts To Medicare Drug Program
The full D.C. Circuit won't rethink a panel's decision that the U.S. Department of Health and Human Services lawfully cut billions of dollars from reimbursements for drugs bought through a discount...To view the full article, register now.
Already a subscriber? Click here to view full article